|
|
Volumn 9, Issue 11, 2010, Pages 825-827
|
|
Modifying protein misfolding
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
2101;
AFEGOSTAT;
AGENTS ACTING ON THE PERIPHERAL NERVOUS AND NEUROMUSCULAR SYSTEMS;
AGENTS AFFECTING METABOLISM;
AMYLOID BETA PROTEIN;
AT 1001;
AT 2220;
BINDING PROTEIN;
COPPER ZINC SUPEROXIDE DISMUTASE;
DUVOGLUSTAT;
MIGALASTAT;
PREALBUMIN;
RAPAMYCIN;
TAFAMIDIS;
TAR BINDING PROTEIN 43;
TRANSMEMBRANE CONDUCTANCE REGULATOR;
UNCLASSIFIED DRUG;
ALZHEIMER DISEASE;
AMYLOID CARDIOMYOPATHY;
AMYLOID NEUROPATHY;
AMYOTROPHIC LATERAL SCLEROSIS;
AUTOPHAGY;
CARDIOMYOPATHY;
CLINICAL TRIAL;
COMBINATION CHEMOTHERAPY;
CYSTIC FIBROSIS;
DRUG DEVELOPMENT;
DRUG INDUSTRY;
DRUG MECHANISM;
ENDOPLASMIC RETICULUM;
FABRY DISEASE;
HUMAN;
PARKINSON DISEASE;
PRIORITY JOURNAL;
PROTEIN DEGRADATION;
PROTEIN MISFOLDING;
PROTEIN STABILITY;
PROTEIN STRUCTURE;
PROTEIN TARGETING;
SHORT SURVEY;
ANIMALS;
DRUG DELIVERY SYSTEMS;
DRUG INDUSTRY;
HUMANS;
NERVOUS SYSTEM DISEASES;
PROTEIN FOLDING;
PROTEINS;
RARE DISEASES;
|
|
EID: 78049468442
PISSN: 14741776
EISSN: 14741784
Source Type: Journal
DOI: 10.1038/nrd3316 Document Type: Short Survey |
|
Times cited : (9)
|
|
References (0)
|
